These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7526017

  • 1. Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study.
    Samma S, Momose H, Ozono S, Hirao Y, Okajima E, Morii T, Nishikawa K, Shimoyama T, Fujimura Y.
    Jpn J Clin Oncol; 1994 Oct; 24(5):269-74. PubMed ID: 7526017
    [Abstract] [Full Text] [Related]

  • 2. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K, Mullaney M, Klumpp T, Goldberg S, Macdonald J.
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [Abstract] [Full Text] [Related]

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 4. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y, Takaue Y, Watanabe T, Saito S, Abe T, Hirao A, Sato J, Ninomiya T, Suzue T, Koyama T.
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [Abstract] [Full Text] [Related]

  • 5. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M.
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 9. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy.
    Kobayashi N, Kasai M, Masauzi N, Ogasawara M, Kiyama Y, Naohara T, Higa T, Hashino S, Tanaka J, Imamura M.
    Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821
    [Abstract] [Full Text] [Related]

  • 10. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S, Ross AA, Layton TJ, Ostrander AB, Goldstein LC, Porter K, Ho AD.
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [Abstract] [Full Text] [Related]

  • 11. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A, Takeyama K, Narabayashi M, Okamoto R, Adachi I, Tobinai K, Shimoyama M.
    Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
    [Abstract] [Full Text] [Related]

  • 14. Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.
    D'Hondt V, Guillaume T, Humblet Y, Doyen C, Chatelain B, Feyens AM, Staquet P, Osselaer JC, Müll B, Symann M.
    Bone Marrow Transplant; 1994 Mar; 13(3):261-4. PubMed ID: 7515299
    [Abstract] [Full Text] [Related]

  • 15. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells.
    Pierelli L, Menichella G, Scambia G, Teofili L, Iovino S, Serafini R, Benedetti Panici P, Salerno G, Rumi C, Zini G.
    Bone Marrow Transplant; 1994 Jul 15; 14(1):23-30. PubMed ID: 7524905
    [Abstract] [Full Text] [Related]

  • 18. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
    Watanabe H, Watanabe T, Suzuya H, Wakata Y, Kaneko M, Onishi T, Okamoto Y, Abe T, Kawano Y, Kagami S, Takaue Y.
    Bone Marrow Transplant; 2006 Apr 15; 37(7):661-8. PubMed ID: 16489358
    [Abstract] [Full Text] [Related]

  • 19. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J, Moraleda JM, Ortuño F, Lozano ML, Ayala F, Vallejo C, de Arriba F, Vicente V.
    Bone Marrow Transplant; 2000 Feb 15; 25(3):231-5. PubMed ID: 10673692
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.